Cargando…
Combined intra-arterial and intra-muscular transfer of Wharton’s jelly mesenchymal stem/stromal cells in no-option critical limb ischemia – CIRCULATE N-O CLI Pilot Study
INTRODUCTION: Despite progress in pharmacologic and revascularization therapies, no-option critical limb ischemia poses a major clinical and societal problem. Prior cell-based strategies involved mainly autologous (limited) cell sources. AIM: To evaluate the safety and feasibility of a novel ischemi...
Autores principales: | Kwiatkowski, Tomasz, Zbierska-Rubinkiewicz, Katarzyna, Krzywon, Jerzy W., Majka, Marcin, Jarocha, Danuta, Kijowski, Jacek, Brzychczy, Andrzej, Musialek, Piotr, Trystula, Mariusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031676/ https://www.ncbi.nlm.nih.gov/pubmed/36967850 http://dx.doi.org/10.5114/aic.2022.120963 |
Ejemplares similares
-
Cellular therapies in no-option critical limb ischemia: present status and future directions
por: Kwiatkowski, Tomasz, et al.
Publicado: (2022) -
Myocardial regeneration strategy using Wharton's jelly mesenchymal stem cells as an off-the-shelf ‘unlimited’ therapeutic agent: results from the Acute Myocardial Infarction First-in-Man Study
por: Musialek, Piotr, et al.
Publicado: (2015) -
Acute myocardial infarction reparation/regeneration strategy using Wharton’s jelly multipotent stem cells as an ‘unlimited’ therapeutic agent: 3-year outcomes in a pilot cohort of the CIRCULATE-AMI trial
por: Kwiecien, Ewa, et al.
Publicado: (2022) -
The Treasury of Wharton's Jelly
por: Guenther, Rebecca, et al.
Publicado: (2021) -
AFM-based Analysis of Wharton’s Jelly Mesenchymal Stem Cells
por: Szydlak, Renata, et al.
Publicado: (2019)